期刊文献+

负载U266细胞抗原的树突状细胞诱导T细胞的抗骨髓瘤活性 被引量:2

Anti-myloma Activity of T cell Activated by Dentritic Cells Loading Antigen of U266 Cells
下载PDF
导出
摘要 本研究探讨负载骨髓瘤U266细胞裂解物的树突状细胞(DC)瘤苗活化的T细胞对U266细胞的体外杀伤作用。用密度梯度离心法分离外周血单个核细胞,然后分别用含重组人粒细胞-巨噬细胞集落刺激因子(GM-CSF)、重组人白细胞介素-4(IL-4)的AIM-V无血清培养液和含胎牛血清的RPMI1640培养液体外诱导培养DC,用MTT法检测负载U266细胞全抗原的DC活化的T细胞对U266细胞的杀伤作用。结果表明:健康人外周血来源的单个核细胞用无血清培养液和含血清培养液诱导培养均可得到足够数量的DC,这两种培养液培养的DC在表型上无明显差异。分别用负载U266细胞全抗原的DC+IL-2、成熟DC+IL-2和单独应用IL-2刺激后的T细胞与U266细胞共培养,其对U266细胞的杀伤作用逐渐减弱,负载U266细胞全抗原的DC+IL-2刺激后的T细胞较成熟DC+IL-2刺激后的T细胞对U266细胞的杀伤作用明显,且T细胞对U266细胞的杀伤率随效靶比的增加而升高。结论:用GM-CSF、IL-4诱导培养健康人外周血单个核细胞可以得到不成熟的DC,体外负载U266细胞全抗原的DC可以刺激自体T细胞增殖并能杀伤U266细胞。 This study was aimed to investigate the effect of T cells activated by DCs loaded with whole antigens of U266 cells on the U266 cells survival in vitro. Peripheral blood mononuclear cells were isolated from healthy donor, and adherented on culture plate. Adherent cells were cultured in AIM-V serum-free medium or in RPMI 1640 medium contained 20% fetal bovine serum (FBS), supplemented with granulocyte-macrophage colony stimulating factor (GM- CSF) and interleukin-4 (IL-4). Methyl thiazolyl tetrazolium (MTT) assay was used to evaluate killing rate of U266 cells by T cells activated by DCs loaded with whole antigen of U266 cells. The results showed that DCs derived from peripheral blood mononuclear cells cultured by AIM-V serum-free medium or RPMI 1640 medium containing FBS had similar immunophenotype. T cells activated by DCs loaded with whole antigen of U266 cells or mature DCs might kill U266 cells in a dose-dependent manner. It is concluded, DCs derived from peripheral blood mononuclear cells of healthy donor and loaded with whole antigen of U266 cells can induce anti-myeloma response of T cells in vitro.
出处 《中国实验血液学杂志》 CAS CSCD 2007年第3期581-585,共5页 Journal of Experimental Hematology
基金 北京市科技新星计划资助项目 编号954812300
关键词 多发性骨髓瘤 树突状细胞 免疫治疗 multiple myeloma dendritic cell immunotherapy
  • 相关文献

参考文献8

  • 1Fields RC,Shimizu K,Mule JJ.Murine dentritic cells pulsed with whole tumor lysates mediates potent antitumor immune responses in vitro and in vivo.Proc Natl Acad Sci USA,1998;95:9482-9487
  • 2Reichardt VL,Milazzo C,Brugger W,et al.Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells.Haematologica,2003;88:1139-1149
  • 3Wen YJ,Min R,Tricot G,et al.Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma:promising effector cells for immunotherapy.Blood,2002;99:3280-3285
  • 4Raje N,Hideshima T,Davies FE,et al.Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma.Br J Haematol,2004;125:343-352
  • 5Feuerstein B,Berger TG,Maczek C,et al.Amethod for the production of cryopreserved aliquots of antigen preloaded,mature dendritic cells ready for clinic use.J Immunol Medthod,2000;245:15-29
  • 6Pecher G,Schirrmann T,Kaiser I,et al.Efficient cryopmservation of dendritic cells transfected with cDNA of a tumour antigen for clinical application.Biotechnol Appl Biochem,2001;34:161-166
  • 7VERG Véronique,MARTINACHE Chantal,LEON Anne,GORIN Norbert-Claude,BERNARD Jacky,LOPEZ Manuel.从单核细胞分化的树突状细胞的低温保存及其临床应用(英文)[J].中国实验血液学杂志,2000,8(4):245-250. 被引量:6
  • 8Fonteneau JF,Larsson M,Bhardwaj N,et al.Interactions between dead cells and dendritic cells in induction of antiviral CTL responses.Curr Opin Immunol,2002;14:471-477

二级参考文献24

  • 1NestleFO,AlijagicS,GillietM,etal.Vaccinationofmelanomapatientswithpeptide-ortumorlysate-pulseddendriticcells.NatMed,1998;4:328-332
  • 2TjoaBA,EricksonSJ,BowesVA,etal.Follow-upevaluationofprostatecancerpatientsinfusedwithautologousdendriticcellspulsedwithPSMApeptides.Prostate,1997;32:272-278
  • 3HsuFJ,BenikeC,FagnoniF,etal.VaccinationofpatientswithB-celllymphomausingautologousantigenpulseddendriticcells.NatMed,1996;2:52-58
  • 4BanchereauJ,SteinmanRM.Dendriticcellsandthecontrolofimmunity.Nature,1998;392:245-252
  • 5RoskrowMA,DillooD,SuzukiN,etal.Autoimmunediseaseinducedbydendriticcellimmunizationagainstleukemia.LeukRes,1999;23:549-557
  • 6KhannaA,SteptoeRJ,AntonysamyMA,etal.Donorbonemarrowpotentiatestheeffectoftacrolimusonnonvascularizedheartallograftsurvival:associationwithmicrochimerismandgrowthofdonordendriticcellprogenitorsfromrecipientbonemarrow.Transplantation,1998;65:479-485
  • 7CameronPU,FreudenthalPS,BarkerJM,etal.Dendriticcellsexposedtohumanimmunodeficiencyvirustype-1transmitavigorouscytopathicinfectiontoCD4+Tcells.Science,1992;257:383-387
  • 8NiedaM,NicolA,KikuchiA,etal.Dendriticcellsstimulatetheexpansionofbcr-ablspecificCD8+Tcellswitheytotoxicactivityagainstleukemiccellsfrompatientswithchronicmyeloidleukemia.Blood,1998;91:977-983
  • 9AustynJM.Antigenuptakeandpresentationbydendriticleukocytes.SeminImmunol,1992;4:227-236
  • 10SallustoF,LanzavecchiaA.Efficientpresentationofsolubleantigenbyculturedhumandendriticcellsismaintainedbygranulocyte/macrophagecolony-stimulatingfactorplusinterleukin4anddownregulatedbytumornecrosisfactorα.JExpMed,1994;179:1109-1118

共引文献5

同被引文献39

  • 1王娟,陶贞霞,刘荣英,曹艳丽,许卫星,李静,沈杰,王庆,王瑞环,赵芳,刘春燕,张睿,张敏娟,马洪玉,苏国宏.DC-CIK细胞免疫治疗恶性肿瘤的临床研究[J].免疫学杂志,2009,25(1):71-74. 被引量:16
  • 2张侠,刘端,李慧莉.感染对肿瘤患者T淋巴细胞核仁区嗜银蛋白含量的影响[J].免疫学杂志,2005,21(4):349-349. 被引量:4
  • 3Wang S,Hong S,Wezeman M,et al.Dendritic cell vaccine but not idiotype-KLH protein vaccine primes therapeutic tumor-specific immunity against multiple myeloma.Front Biosci,2007, 12:3566-3575
  • 4Van de-Velde AL,Berneman ZN,Van Tendeloo VF.Immunotherapy of hematological malignancies using dendritic cells.Bull Cancer,2008, 95:320-326
  • 5Hundemer M,Schmidt S,Condomines M,et al.Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.Exp Hematol,2006,34:486-496
  • 6Rew SB,Peggs K,Sanjuan I,et al.Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24.Clin Cancer Res,2005 , 11:3377-3384
  • 7Qian J,Xie J,Hong S,et al.Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.Blood,2007, 110:1587-1594
  • 8Dadabayev AR,Wang Z,Zhang Y,et al.Cancer immunotherapy targeting Sp17:when should the laboratory findings be translated to the clinics? Am J Hematol,2005 , 80:6-11
  • 9Lee JJ,Choi BH,Kang HK,et al.Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates.Leuk Lymphoma,2007 , 48:2022-2031
  • 10Hayashi T,Hideshima T,Akiyama M,et al.Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes.Blood,2003 ,102:1435-1442

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部